TAMMY FREEMAN: Open Payments
NPI 1023105780 · GRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 12 payments from 5 companies in 2025. Trend: 2023 $325 · 2024 $569 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| ABBVIE INC. | 5 | $77 |
| Astellas Pharma US Inc | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: VRAYLAR, FARXIGA, TEZSPIRE, Veozah, Rybelsus, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
